Cost-Effectiveness of isoniazid preventive therapy among HIV-infected patients clinicaly screened for latent tuberculosis infection in Dar es Salaam, Tanzania: A prospective Cohort study

BACKGROUND: One of the reasons why Isoniazid preventive therapy (IPT) for Tuberculosis (TB) is not widely used in low income countries is concerns on cost of excluding active TB. We analyzed the cost-effectiveness of IPT provision in Tanzania having ruled out active TB by a symptom-based screening t...

Descripción completa

Detalles Bibliográficos
Autores principales: Shayo, Grace A., Chitama, Dereck, Moshiro, Candida, Aboud, Said, Bakari, Muhammad, Mugusi, Ferdinand
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5518094/
https://www.ncbi.nlm.nih.gov/pubmed/28724374
http://dx.doi.org/10.1186/s12889-017-4597-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5518094/
https://www.ncbi.nlm.nih.gov/pubmed/28724374
http://dx.doi.org/10.1186/s12889-017-4597-9

Ejemplares similares